Mustard Seed Investor logo: a sprouting mustard seedMustard Seed Investor
← All stocks
No tickerHealth CareCommon Stock

Amicus Therapeutics Inc

Held by 0 tracked managers as of Q2 2026 · CUSIP ⓘCUSIP: A 9-character ID for one specific security - one share class of one company, or one bond. Tickers can change and can mean different things in different countries; a CUSIP always identifies exactly the same security, which is why filings use it. Guide 03152W109 · Sector ⓘGICS sectors: The 11-sector system most investors know (Global Industry Classification Standard): Technology, Health Care, Financials and so on. This site assigns each company a GICS-style sector from its SIC code, with a few hand corrections, so sector pages match the names investors expect. Guide

Download report
In plain English: 0 of the investors we track own this stock. In the latest quarter, 0 of them bought more of it and 10 sold some or all of theirs. That tells you what they did last quarter — not what the stock will do next.

Educational and informational only, not personalized investment advice. Based on public filings that may be delayed or contain errors; verify with the original filings. Disclaimer

Managers holding
0
-10 vs last quarter (like-for-like)
Total value held
$0
Across tracked managers
Average weight ⓘOn average, how big this stock is in the portfolios that own it (its share of each manager's reported portfolio value).
—
Of each manager's book
QoQ value ⓘLike-for-like: only managers that filed both quarters are compared, so a manager filing late (or confidentially) does not look like buying or selling. Includes price changes.
-$344.28M
-100.0% vs last quarter
Net shares bought
-23.8M
Est. net flow -$344.28M
Quarter activity
0 bought · 10 sold
0 new · 10 sold out

Tracked capital in this stock

Total value held (area) and number of managers (line). Dips can mean a large holder filed that quarter confidentially (e.g. Norges Bank in Q1/Q3).

Chart: Tracked capital in this stock

Aggregate buying and selling

Net share change reported each quarter

Chart: Aggregate buying and selling

Who owns Amicus Therapeutics Inc?

🔒 The 'who added and who trimmed' chart is a Plus feature

You're viewing the Free plan. Upgrade to unlock The 'who added and who trimmed' chart — every paid plan starts with a 7-day free trial, and you can cancel in two clicks.

See plans & upgrade Sign in

Who owns Amicus Therapeutics Inc? — Q2 2026

Holders ranked by position size, with each one's quarter-over-quarter change.

CSV Excel
All Only new positions Only increased Only reduced
Column filters

Numbers accept 1.5M, 2B, 250K. Percent columns take percent (5 = 5%).

Nothing to show yet.

Sold out completely this quarter

CSV Excel
Column filters

Numbers accept 1.5M, 2B, 250K. Percent columns take percent (5 = 5%).

Manager Fund Shares sold Value last quarter ↓
Israel Englander Millennium Management -7.9M $114.36M
Cliff Asness AQR Capital Management -5.8M $84.50M
George Soros Soros Fund Management -5.8M $83.19M
Jim Simons Renaissance Technologies -1.9M $27.08M
Jeremy Grantham GMO -941.3K $13.61M
Two Sigma Two Sigma Investments -781.7K $11.30M
David Shaw D.E. Shaw & Co. -488.1K $7.06M
Ken Griffin Citadel Advisors -124.8K $1.80M
Steve Cohen Point72 Asset Management -54.7K $790.63K
Mario Gabelli GAMCO Investors -40.0K $578.40K

Politician trades

Politician trades in this stock

CSV Excel
Chamber BothHouseSenate
Party AllDemocratsRepublicansIndependents
Traded Any timeLast 30 daysLast 90 daysLast 12 months
All Purchases Sales Exchanges Large: $50K+ Very large: $250K+ Filed late (45+ days)
Column filters

Numbers accept 1.5M, 2B, 250K. Percent columns take percent (5 = 5%).

No politician trades match these filters.